It's Friday, May 11th, 2018, and you're listening to Up to Date. I'm Indravis Gontas.

And I'm Kishar Harri. All right. Let's rewind the clock. Both of us have kids.

Yeah. And, but let's go back to that time when we were sort of planning on getting pregnant.

Can we go a little bit further? Yeah, I wish we could go further. I think that was the good time.

It was, it was, for me, I will say it was a stressful period. It was. But there's now technology

available that at least wasn't available in the same way it was back then. You can get a whole genome

sequence now. Now, that's not sort of available in a consumer way. It's still pretty

expensive, but it can be done. With the idea of if you get a whole genome sequence, you can

get any sort of medically relevant information on rare diseases or any sort of risks up front.

And then you can also get access to sort of long-term

risk. So a new study came out from Sue Richards, who's at Oregon Health Sciences University,

that was in the American Journal of Human Genetics, that screened 131 women and their partners,

and a total of about 200 people participated and had their whole genome

sequence.

And they were given the information.

And first they told them any sort of life-threatening, like very actionable information was

immediately given to the people.

Like you have, you know, a Brecka positive.

Yeah.

Or Huntington's disease.

You know, something like, you know, pretty important.

But then they were given a choice.

...